Skip to content
healthcare.dev

Atazanavir Sulfate

NDC 65862-713, Atazanavir, capsule, from Aurobindo Pharma Limited.

Product NDC
65862-713
Status
Listed
Labeler
Aurobindo Pharma Limited
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA204806
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/65862-713 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ATAZANAVIR SULFATE300 mg/1

Pharmacologic classes

Cytochrome P450 2C8 Inhibitors [MoA]; Cytochrome P450 3A Inhibitors [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; HIV Protease Inhibitors [MoA]; Protease Inhibitor [EPC]; UDP Glucuronosyltransferases Inhibitors [MoA]; UGT1A1 Inhibitors [MoA]

Package NDCNDC-11Package
65862-713-03658620713033 BLISTER PACK in 1 CARTON (65862-713-03) / 10 CAPSULE in 1 BLISTER PACK (65862-713-10)
65862-713-0565862071305500 CAPSULE in 1 BOTTLE (65862-713-05)
65862-713-306586207133030 CAPSULE in 1 BOTTLE (65862-713-30)
65862-713-906586207139090 CAPSULE in 1 BOTTLE (65862-713-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/7fbea274-d6b5-4faa-bbf0-05fefab42114
  • NADAC price for package 65862071330

    GET /v1/drugs/nadac/65862071330

Use it

Look up 65862-713 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/65862-713 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 65862-713. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.